The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksC&C Group Regulatory News (CCR)

Share Price Information for C&C Group (CCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 166.40
Bid: 166.40
Ask: 167.00
Change: -0.60 (-0.36%)
Spread: 0.60 (0.361%)
Open: 167.80
High: 168.60
Low: 166.00
Prev. Close: 167.00
CCR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

4 Nov 2020 14:15

RNS Number : 2789E
C&C Group Plc
04 November 2020
 

C&C Group plc

 

Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them

 

On 3 November 2020, the Company approved the grant to David Forde of two awards in the form of nil-cost options over ordinary shares in the Company. These awards are compensation for remuneration arrangements forfeited by David Forde on leaving his previous employer and were agreed as part of his recruitment package, as announced on 9 July 2020.

 

Buy-Out Award

Number of Shares

Vesting Date

Buy-Out Award 1

421,318

3 November 2022

Buy-Out Award 2

421,318

3 November 2023

 

The share price used to calculate the number of awards was the mid-market closing price on the dealing day prior to grant (2 November 2020). The awards will vest on the dates provided above, subject to Mr Forde's continued service with the Company.

 

The awards have been granted in reliance on FCA Listing Rule 9.4.2(2). As noted in the announcement of 9 July, the full terms of Mr Forde's remuneration package will be included in the Company's Directors' Remuneration Report for the year ending in 2021.

 

Contact

 

Mark Chilton, Company Secretary

C&C Group plc

Bulmers House

Keeper Road

Crumlin

Dublin 12

D12 K702

 

 1

Details of the person discharging managerial responsibilities/person closely associated 

a)

Name

David Forde

2

Reason for the notification 

a)

Position/status

Person Discharging Managerial Responsibilities (Chief Executive Officer)

b)

Initial Notification Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

C&C Group plc

b)

LEI

635400LNUHA2LDXXV850 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of €0.01 each

Identification code

ISIN: IE00B010DT83

b)

Nature of the transaction

Grant of options to acquire Ordinary Shares of €0.01 each

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

421,318 ("Buy-Out Award 1")

Nil

421,318 ("Buy-Out Award 2")

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

 

842,636

 

Nil

 

e)

Date of the transaction

3 November 2020

f)

Place of the transaction

Outside a trading venue 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEALFLEESEFFA
Date   Source Headline
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20244:30 pmRNSDirector/PDMR Shareholding
16th Apr 202410:30 amRNSDirector/PDMR Shareholding
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20245:15 pmRNSTotal Voting Rights and Capital
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20243:25 pmRNSDirector/PDMR Shareholding
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
29th Feb 20242:55 pmRNSTotal Voting Rights and Capital
22nd Feb 20245:31 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSLaunch of EUR 15 Million Share Buyback Programme
15th Feb 20246:00 pmRNSDirector/PDMR Shareholding
15th Feb 20247:00 amRNSDirectorate Changes
2nd Feb 202410:00 amRNSTotal Voting Rights and Capital
15th Jan 20242:20 pmRNSDirector/PDMR Shareholding
4th Jan 202412:45 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.